Compare Mutual Funds
Pros | Beats FD returns for both 3Y & 5Y duration. | Larger AUM within category. Beats FD returns for both 3Y & 5Y duration. | ||
Cons | 3Y returns in the bottom 25% of the category. | 5Y returns in the bottom 25% of the category. 3Y returns in the bottom 25% of the category. |
INDMoney rank | 4/8 | 8/8 | ||
Category | Equity, Sector - Healthcare | Equity, Sector - Healthcare | ||
Fund Age | 10 Years 8 Months | 13 Years 8 Months | ||
Fund AUM | ₹1387 Cr | ₹8636 Cr | ||
Min Investment |
|
| ||
Expense Ratio | 0.67% | 0.79% | ||
Exit Load | 0.25% | 1% | ||
Benchmark Index | Nifty Pharma TR INR | BSE Healthcare TR INR |
No of Holdings | 40 | 37 | ||
Top 5 Holdings |
|
| ||
No of Sectors | 4 | 1 | ||
Top 3 Sectors |
| Health (100%) | ||
Equity % | 99.3% | 97.92% | ||
Debt % | - | - | ||
P/E | 40.45 | 36.71 | ||
P/B | 6.4 | 5.41 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | 6.17% | 6.46% | ||
3-Month Return | 17.93% | 16.52% | ||
6-Month Return | 8.77% | 10.62% | ||
1-Year Return | 9.27% | 9.5% | ||
3-Year Return | 23.63% | 22.56% | ||
5-Year Return | 15.03% | 13.75% |
Sharpe | 0.94 | 0.97 | ||
Alpha | -0.31 | -0.78 | ||
Beta | 0.98 | 0.89 | ||
Standard Deviation | 16.77 | 15.23 | ||
Information Ratio | -0.18 | -0.76 |
Description | Tata India Pharma & Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run. | Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Rajat Srivastava | Sailesh Raj Bhan, Kinjal Desai, Amber Singhania |

